Express News | Toho Hd 2023/24 Group Operating Profit 19.33 Bln Yen (+18.1 %), 2024/25 Forecast Profit 18.20 Bln Yen (-5.9 %)
Express News | Toho Hd 2023/24 Group Net Profit 20.66 Bln Yen (+51.5 %), 2024/25 Forecast Profit 12.50 Bln Yen (-39.5 %)
Toho Holdings FY Net Y20.66B Vs Net Y13.63B
Toho Holdings Co. Ltd. (8129.TO) Japan Year Ended March 31 GROUP 2024 2023 Revenue Y1.48 tln Y1.39 tln Operating Profit Y19.33 bln Y16.3
The China Securities Convertible Index rose 0.03% at the beginning of the market. Xuerong Convertible Bonds rose more than 16%, Dongbao Convertible Bonds rose more than 8%, and Titan Convertible Bonds rose more than 5%.
The China Securities Convertible Index rose 0.03% at the beginning of the market. Xuerong Convertible Bonds rose more than 16%, Dongbao Convertible Bonds rose more than 8%, and Titan Convertible Bonds rose more than 5%.
Artificial meat concept stocks opened sharply, Xuerong Biotech and Shuangta Foods rose and stopped, and Sihuan Biotech, Jiahua, Dongbao Biotech, and Suobao Protein strengthened one after another.
Artificial meat concept stocks opened sharply, Xuerong Biotech and Shuangta Foods rose and stopped, and Sihuan Biotech, Jiahua, Dongbao Biotech, and Suobao Protein strengthened one after another.
Express News | Tonghua Dongbao: Deputy General Manager Chen Hong plans to reduce his holdings by no more than 70,000 shares
Jefferies Adjusts Toho Titanium's Price Target to 2,250 Yen From 2,750 Yen, Keeps at Buy
05:00 AM EDT, 05/09/2024 (MT Newswires) -- Jefferies Adjusts Toho Titanium's Price Target to 2,250 Yen From 2,750 Yen, Keeps at Buy
Express News | Toho Titanium 2023/24 Group Operating Profit 5.63 Bln Yen (-47.4 %), 2024/25 Forecast Profit 5.70 Bln Yen (+1.3 %)
Toho Titanium Co Sees FY Net Y3.70B
Toho Titanium Co. Ltd. also released the following forecasts: GROUP 1st Half To Year Ending Sep 2024 Mar 2025 Revenue Y45.30 bln Y95.30 bln
Tonghua Dongbao (600867.SH) plans to take a stake in the cutting-edge protein drug innovation company Junhe League to extend its business to the consumer medicine sector
Tonghua Dongbao (600867.SH) announced that the company, as a Series B investor, will invest in Junhe Biopharmaceuticals (Hangzhou) Co., Ltd. (“Junhe” or the “target company”) through a capital increase of 100 million yuan to obtain 8.6759% of the company's shares on a fully diluted basis after the capital increase is completed.
Express News | Tonghua Dongbao: Plans to increase capital to Junhe League by 100 million yuan
Express News | Tonghua Dongbao announced that it will invest in Junhe Biopharmaceutical (Hangzhou) Co., Ltd. in the form of a capital increase of 100 million yuan with its own capital to obtain 8.6759% of the company's shares on a fully diluted basis after the capital i
Yunlou Stock List (Weekly Chart) [Ichimoku Equilibrium Chart/Cloud Stock List]
○Kumojo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime <1417> Mirite One 1928 1923 1753 <1518> Mitsui Matsushima HD 3440 2804.75 3290 <1803> Shimizu 1003 995.75 891.5 <2206> Glico
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <2124> JACR 735 772 <2489> ADWAYS 406 458 <2742> Hello's 4515 4850 <3232> Mie Kotsu GHD 584 625 <3673> Brodreef 564
Express News | Tonghua Dongbao: Phase IIa clinical trial of gout dual-target inhibitors (THDBH151 tablets) completed the first patient administration.
Jefferies Adjusts Toho Holdings' Price Target to 4,400 Yen From 3,800 Yen, Keeps at Buy
05:51 AM EDT, 05/01/2024 (MT Newswires) -- Jefferies Adjusts Toho Holdings' Price Target to 4,400 Yen From 3,800 Yen, Keeps at Buy
Express News | Toho Hd -Revises 2023/24 Group Operating Forecast to Profit 19.30 Bln Yen From Profit 12.60 Bln Yen (+53.2%)
Toho Holdings Raises FY Net View to Y20.60B
GROUP New Forecast Prior For Year To Mar 2024 Forecast Revenue Y1.48 tln Y1.46 tln Operating Profit Y19.30 bln
Express News | Tonghua Dongbao: Toku's clinical application for insulin liraglutide injection was approved
Tonghua Dongbao (600867.SH) announced first-quarter results, net profit of 215 million yuan, a year-on-year decrease of 14.28%
Tonghua Dongbao (600867.SH) disclosed its report for the first quarter of 2024. During the reporting period, the company achieved revenue of 591 million yuan, a year-on-year decrease of 11.12%; net profit to mother was 215 million yuan, a year-on-year decrease of 14.28%; after deducting non-net profit of 215 million yuan, a year-on-year decrease of 13.01%. Basic earnings per share were $0.11.
No Data